Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma

Fig. 3

Assessment of the predictive power of the prognostic signature. a Kaplan–Meier analysis of OS in the high-risk and low-risk groups in the training set, d testing set and (g) total set. b Time-independent ROC analysis of risk scores for predicting OS in the training set, (e) testing set and (h) total set. c The distribution of risk scores, survival status and expression level of 9 prognostic proteins in the training set, (f) testing set and (i) total set

Back to article page